Predictability of post-delivery mitral regurgitation with a new generation transcatheter edge-to-edge device
M-TEER using the PASCAL Precision system demonstrates stable intraprocedural MR outcomes, with over 90% of cases showing no deterioration from pre- to post-release, irrespective of valve complexity or etiology.
Authors
- Muhammed Gerçek (ORCID: https://orcid.org/0000-0002-1822-936X)
- Volker Rudolph (ORCID: https://orcid.org/0000-0001-5385-6839)
- Felix Rudolph (ORCID: https://orcid.org/0000-0003-4948-6438)
- Katharina Hellhammer (ORCID: https://orcid.org/0000-0003-1287-4605)
- Peter Luedike
- Amir Abbas Mahabadi (ORCID: https://orcid.org/0000-0003-2336-7991)
- Florian Schindhelm (ORCID: https://orcid.org/0000-0002-5870-9675)
- Tienush Rassaf (ORCID: https://orcid.org/0000-0001-8001-0265)
- Andreas Goldschmied (ORCID: https://orcid.org/0000-0002-0168-1755)
- Matthias Totzeck (ORCID: https://orcid.org/0000-0001-7898-3906)
- Tobias Geisler (ORCID: https://orcid.org/0000-0002-8864-6038)
- Isabela Kast
Institutions
- Heart and Diabetes Center North Rhine-Westphalia (DE)
- West German Heart and Vascular Center Essen (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1007/s00392-025-02705-5
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Edwards Lifesciences
- Universitätsklinikum Essen